This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 105/4/326    most recent CIRCRESAHA.109.200501v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lamounier-Zepter, V. Articles by Morano, I. Search for Related Content PubMed PubMed Citation Articles by Lamounier-Zepter, V. Articles by Morano, I. Related Collections Contractile function Other heart failure Calcium cycling/excitation-contraction coupling Heart failure - basic studies

(Circulation Research. 2009;105:326.)
© 2009 American Heart Association, Inc.

Cellular Biology

Adipocyte Fatty Acid–Binding Protein Suppresses Cardiomyocyte Contraction

A New Link Between Obesity and Heart Disease

Valéria Lamounier-Zepter, Christiane Look, Julio Alvarez, Torsten Christ, Ursula Ravens, Wolf-Hagen Schunck, Monika Ehrhart-Bornstein, Stefan R. Bornstein, Ingo Morano

From the Medical Clinic III (V.L.-Z., C.L., M.E.-B., S.R.B.), Dresden University of Technology, Germany; Institute of Cardiology (J.A.), La Habana, Cuba; Department of Pharmacology and Toxicology (T.C., U.R.), Dresden University of Technology, Germany; Max-Delbrueck-Center for Molecular Medicine (W.-H.S., I.M.), Berlin-Buch, Germany; and University Medicine Charité (I.M.), Berlin, Germany.

Correspondence to Valéria Lamounier-Zepter, Medical Clinic III, Dresden University of Technology, Fetscherstr. 74, 01307 Dresden, Germany. E-mail Valeria.Zepter{at}uniklinikum-dresden.de

Rationale: Adipocyte fatty acid–binding protein (FABP4) is a member of the intracellular lipid-binding protein family and is predominantly expressed in adipose tissue. Emerging evidence suggests that FABP4 plays a role in some aspects of the metabolic syndrome including the development of type 2 diabetes and atherosclerosis. We have recently reported that secretory products from human adipocytes directly and acutely depressed cardiac contractile function.

Objective: The purpose of this study was to identify this adipocyte-derived cardiodepressant factor.

Methods and Results: Through mass spectrometry and immunoblotting, we have identified this cardiodepressant factor as FABP4. FABP4 represents 1.8% to 8.1% of total protein secreted by adipocytes in extracellular medium. FABP4 acutely depressed shortening amplitude as well as intracellular systolic peak Ca²⁺ in a dose-dependent manner in isolated rat cardiomyocytes. Heart-specific FABP isoform (FABP3) revealed a similar cardiodepressant effect. The N-terminal amino acids 1 to 20 of FABP4 could be identified as the most effective cardiodepressive domain. We could exclude any effect of FABP4 on action potential duration and L-type Ca²⁺ current, suggesting a reduced excitation-contraction gain caused by FABP4 as the main inhibitory mechanism.

Conclusion: We conclude that the release of FABP4 from adipocytes may be involved in the development of cardiac contractile dysfunction of obese subjects.

Key Words: FABP4 • heart failure • adipocytes • metabolic syndrome